{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:58:04Z","timestamp":1782255484545,"version":"3.54.5"},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.2022-11-6","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T10:49:58Z","timestamp":1677494998000},"page":"1-13","source":"Crossref","is-referenced-by-count":8,"title":["Upadacitinib for the treatment of psoriatic arthritis"],"prefix":"10.7573","volume":"12","author":[{"given":"Diogo","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10047","published-online":{"date-parts":[[2023,2,28]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2023\/02\/dic.2022-11-6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T10:49:59Z","timestamp":1677494999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/upadacitinib-for-the-treatment-of-psoriatic-arthritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.2022-11-6","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]}}}